Tamper Evident Caps Market Size, Share & Trends Analysis | United States | 2012-2018 | MedSuite | Segmented by: Device Type (Sterile & Oral Tamper Evident Caps)
- Year: 2012
- Scope: 2008-2018
- Region: United States
- Pages: 42
- Published Date: 10/1/2013
- Type: MedSuite
Summary for: Main Segments Included:
Prefilled Syringes and Tamper Evident Devices
Prefilled Syringe Administration Types
Sub-Segments Included:
Oral Tamper Evident Cap Market
Sterile Tamper Evident Cap Market
Plastic Prefilled Syringes
Glass Prefilled Syringes
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
| Report Summary | FREE |
Tamper Evident Caps Market Size, Share & Trends Analysis | United States | 2012-2018 | MedSuite | Segmented by: Device Type (Sterile & Oral Tamper Evident Caps)
$295 – $9,995
In the United States, the administration of drugs through intravenous or intramuscular injection (parenterally) has been consistently rising since the 1990s. These injections are being performed not only through the traditional method of drawing a fluid from a vial or ampoule into a syringe through a hypodermic needle at the time of administration, but also through prefilled syringes. A doctor or nurse filling a syringe just before use can be a time-consuming process that can also increase the likelihood of incorrect dosage or the patient and medical professional being exposed to a caustic or otherwise harmful substance. Prefilled syringes not only address drug and device manufacturers concerns about drug overfill but also customers increasing concerns over patient safety and increasing procedural costs. Prefilled syringes are convenient and cost-effective devices that can be easily stored and disposed of, and they increase the likelihood of the drug being sterile and having the proper dosage, which is becoming an increasingly important factor as newer high-potency, longer-lasting drugs are being used across the medical industry.
- 2012
- 2008-2018
- United States
- 10/1/2013
- 42
- MedSuite
Related Reports
